scATACseq: Single-Cell ATAC Sequencing Analytical Validation (MD Anderson)
BRD ID: 3,114
Source: CIMAC-CIDC Network Tier: SOP Number of times downloaded: 336
Description
This assay analytical validation and performance report describes the methods used to validate a single cell Assay for Transposase-Accessible Chromatin (ATAC) sequencing for the analysis of cryopreserved melanoma tumor cells and tumor infiltrating lymphocytes (TIL) isolated from patients diagnosed with metastatic melanoma. The document also presents data supporting the reported accuracy, precision, and analytical sensitivity. It is used by a Cancer Immune Monitoring and Analysis Center (CIMAC) at MD Anderson Cancer Center. It is a product of the CIMAC and Cancer Immunologic Data Center Network (CIMAC-CIDC Network; https://dctd.cancer.gov/research/networks/precision-medicine-oncology/cimac-cidc).
Documents for Download
Analytical report_scATACseq_March 2021_MDACC_508_Final.pdf [Size: 9189 KB]Biospecimens
- Cell - Skin
- Cell - White Cells
Diagnoses
- Neoplastic - Melanoma
Topics
- Platform-specific Methodology
Associated SOP Compendiums
- Platform-specific Methodology